All Eyes on Gilead

FromListen to the Story

Start listening View podcast show

All Eyes on Gilead

FromListen to the Story

ratings:

Length:

17 minutes

Released:

May 13, 2020

Format:

Podcast episode

Description

Emergency approval of the antiviral drug remdesivir is the first good news of this pandemic. Gilead Sciences took extraordinary steps to get ready for the moment. By Robert LangrethSee omnystudio.com/listener for privacy information.

Released:

May 13, 2020

Format:

Podcast episode

Titles in the series (100)

Our editors bring you the most interesting reporting from this week in the world of business, finance, tech, and politics.

Skip carousel

Climate-Fried Steak by Listen to the Story
18 min listen
'The Ear Is the New Wrist' by Listen to the Story
22 min listen
The Wealth Detective by Listen to the Story
23 min listen
The Legend of Jacinto's Gold by Listen to the Story
43 min listen
All Over But the Streaming by Listen to the Story
12 min listen
Protesting Like It's 2047 by Listen to the Story
13 min listen
The Rebel Economists of Beijing by Listen to the Story
23 min listen
Miracle Cures in Our Genes by Listen to the Story
15 min listen
The Mystery of the Millionaire Hermit by Listen to the Story
23 min listen
Towing Icebergs From Antarctica to South Africa by Listen to the Story
22 min listen
Unicorn Season by Listen to the Story
6 min listen
Populism in the Land of Genghis Khan by Listen to the Story
23 min listen
They're Coming for Your Eyeballs by Listen to the Story
21 min listen
You Gotta Smash a Few Cars to Make an Autonomous Vehicle by Listen to the Story
22 min listen
Elizabeth Warren Is Done Playing It Safe by Listen to the Story
33 min listen
The Zillion-Dollar Convenience Store by Listen to the Story
21 min listen
The Great Model Train Robbery by Listen to the Story
22 min listen
The Nadellaissance by Listen to the Story
12 min listen
What Bird Brains Can Teach Self-Driving Cars, Siri’s Cousins, and the Chip Elon Wants to Put in Your Skull by Listen to the Story
19 min listen
We Need a New Vision of Technological Progress. We've Got Options by Listen to the Story
10 min listen
Pat O'Gold by Listen to the Story
15 min listen
The People’s Degustation Army by Listen to the Story
14 min listen
King of the Snitches by Listen to the Story
31 min listen
Battle of the Bubbles by Listen to the Story
24 min listen
The New Red Scare by Listen to the Story
28 min listen
How to Hide From Silicon Valley by Listen to the Story
20 min listen
Canopy CEO Bruce Linton Is Your Friendly Canadian Weed Guy by Listen to the Story
22 min listen
Mary Barra Risks It All by Listen to the Story
19 min listen
A Fix for the U.S. Health-Care Crisis: Four Walls and a Roof by Listen to the Story
23 min listen
From Microcredit to Major Debt by Listen to the Story
23 min listen

More Episodes from Listen to the Story

Skip carousel

Fixing Pixar by Listen to the Story
21 min listen
Genohype by Listen to the Story
27 min listen
Tesla's Nordic Rebellion by Listen to the Story
23 min listen
Sextortion by Listen to the Story
36 min listen
How Matzo Is Made by Listen to the Story
8 min listen
Bluey, Take a Bow by Listen to the Story
31 min listen
An Empire Divided by Listen to the Story
22 min listen
Everywhere All at Once by Listen to the Story
29 min listen
Can AI Unlock the Secrets of the Ancient World? by Listen to the Story
23 min listen
That New Contract Smell by Listen to the Story
33 min listen
Pausing Menopause by Listen to the Story
27 min listen
The Legal Netherworld of Deepfakes by Listen to the Story
30 min listen
Master of the Deep by Listen to the Story
37 min listen
Elon Musk's Brain Implant Startup Is Ready to Start Surgery by Listen to the Story
27 min listen
Foxconn's EV Drive by Listen to the Story
25 min listen
The Swiss Solution by Listen to the Story
14 min listen
How to Build the Next BTS by Listen to the Story
24 min listen
Continental Rift by Listen to the Story
24 min listen
Law Enforcement’s Most Troubling Shortcut Is Google by Listen to the Story
24 min listen
Is Working Here the Worst Retail Job in America? by Listen to the Story
27 min listen
Bankman, Fried & Son by Listen to the Story
34 min listen
Another Shot by Listen to the Story
19 min listen
A Fortune in Crypto, Stolen With a Phone by Listen to the Story
39 min listen
The Maddening Mystery of a Murdered Billionaire by Listen to the Story
45 min listen
Actors and Writers Think They've Landed in a Terminator Reboot by Listen to the Story
15 min listen
How Many Points Is a Shot of Wegovy? by Listen to the Story
27 min listen
Jacked by Listen to the Story
52 min listen
How a Huawei Mole Got Caught Trying to Swing a $200 Million 5G Contract by Listen to the Story
28 min listen
America’s Long, Tortured Journey to Build EV Batteries by Listen to the Story
30 min listen

Related podcast episodes

Skip carousel

This Drug Maker Saw the Pandemic Coming by Prognosis: Losing it
14 min listen
Covid Milestones: Eli Lilly CEO on Antiviral Approval, Pfizer’s FDA Application, & Getting Back to the Movies: Pfizer is submitting its application to the FDA for emergency use of its Covid-19 vaccine. If approved, administration of the vaccine could begin before the end of the year. The FDA has approved emergency use of Eli Lilly’s arthritis drug baricitinib in combination with Gilead’s remdesivir to treat Covid-19 patients. Eli Lilly CEO David Ricks and CNBC’s Meg Tirrell discuss distribution, supply, and the path to approval for coronavirus treatments. Plus, IMAX CEO Richard Gelfond is planning ahead for theater reopenings around the world. He shares his own outlook for entertainment, in-person movies, and safety post-pandemic. by Squawk Pod
24 min listen
719. World Vitamin D Day: Did you know it was World Vitamin D Day on November 2nd? Of course Dr. Martin couldn’t pass up the chance to celebrate, what he calls, World VitDerma Day! He brings you a shocking study from researchers at the Trinity College in Dublin, Ireland.... by The Doctor Is In Podcast
26 min listen
TBD | The Rush for Ivermectin: Who’s profiting from the latest unproven COVID treatment craze? by What Next | Daily News and Analysis
25 min listen
What Next TBD: The Rush for Ivermectin: Who’s profiting from the latest unproven COVID treatment craze? by Slate Daily Feed
25 min listen
What Next TBD: The Rush for Ivermectin: Who’s profiting from the latest unproven COVID treatment craze? by Slate News
25 min listen
Is Ivermectin a Covid ‘wonder drug’?: What do we know about the efficacy of Ivermectin as a treatment for Covid-19? by More or Less: Behind the Stats
9 min listen
Pharma and Biotech Daily: Keeping You Informed on the Latest Developments by Pharma and BioTech Daily
3 min listen
Saving the Northern White Rhino: Bringing back the Northern White Rhino from extinction by Unexpected Elements
62 min listen
Genome editing and the future of food: Dan Saladino looks at the future role of genome editing technology on food and farming. by The Food Programme
29 min listen
Biosecurity Imperatives and the Feed Supply: Guests: Dr. Jordan Gebhardt, Kansas State University and Dr. Chad Paulk, Kansas State University Co-host: Dr. Zack Lowman Tonight we are talking feed supply biosecurity and the many challenges we face as we try to keep various animal diseases at bay. In late July, the USDA announced that African Swine Fever was detected in the Dominican Republic, inching dangerously close to the U.S. swine herd. by Real Science Exchange
64 min listen
When There Is No Canine Flu Outbreak, Should We Still Vaccinate?: Now that the canine influenza outbreaks have generally fizzled out, should we continue to vaccinate? Our veterinarian co-hosts weigh in. by The Space Coast Pet Podcast
34 min listen
Cordyceps & Reishi Genetics with Ryan Paul Gates by Mushroom Revival Podcast
62 min listen
Statins and Nocebo, Vit D & Covid, new therapies for Covid: Research trials for Covid-19. Do vitamin D supplements prevent infection from SARS-COV-2? by Inside Health
28 min listen
Media Blackout! FDA Forced to Pull Negative Posts & Papers Related to Ivermectin by Stinchfield with Grant Stinchfield
30 min listen
How Effective Are Antibody Treatments For COVID-19?: Science correspondent Richard Harris explains how monoclonal antibody treatments for COVID-19 work and how effective they're shaping up to be. by Short Wave
12 min listen
Newly approved cervical cancer drug Tivdak gives patients a new option by The BioWorld Insider Podcast
18 min listen
The Insect Crisis with Oliver Milman by Cooking Issues with Dave Arnold
60 min listen
Beyond Covid: Staying Healthy During the Winter Break: In this episode of the Beyond Covid podcast from RANE, the risk intelligence company, Dr. Bill Lang and Dr. Fred Southwick share best practices for beating the "tripledemic" of R.S.V., flu and Covid-19. Dr. Fred Southwick is an infectious disease sp... by RANE Podcast Series
21 min listen
Gorillas: Recovering from COVID-19 by Amazing Wildlife: A San Diego Zoo Podcast
20 min listen
Anti-Viral Drug Remdesivir Shown to Shorten COVID-19 Recovery Time by The Daily Dive
20 min listen
UAP Weekly - part 2 - 6-16-23 Disclosure Project 2.0 - Recapping Reality Changing Claims by UAP Unidentified Alien Podcast
59 min listen
The Impact of COVID-19 on the Supply Chain with Dr. Adriana Sanford: Dr. Adriana Sanford joins hosts Lew Weiss and Tim Grady to discuss the impact of COVID-19 on the supply chain. She has authored two books about the supply chain, in addition to her many other accomplishments. Listen to find out if your manufacturing oper... by Manufacturing Talk Radio
38 min listen
Associate Professor Greg Goodman (Dermatologist ) - 'Injectable complications' #80: Associate Professor Greg Goodman (Dermatologist ) - Injectable complications by Inside Aesthetics
101 min listen
Ep112 - Protecting your birds from Avian Influenza with Dr. Rodrigo Gallardo: In this episode of Bred to Perfection, we are talking with Dr. Rodrigo Gallardo, a Poultry Veterinarian at UC Davis, about HPAI – Highly Pathogenic Avian Influenza. This disease is spreading rapidly, and has shown up in a dozen or more states. In... by Bred to Perfection
56 min listen
Episode 27: Human VH Domains – Finding Antibodies to Treat COVID-19 and Beyond by The Chain: Protein Engineering Podcast
26 min listen
Pharma and Biotech Daily: Medicare Covers Novo's Obesity Drug, FDA Approves Italfarmaco's Duchenne Drug, and More! by Pharma and BioTech Daily
1 min listen
House Hearings Expose Infuriating Truths on COVID, Afghanistan: You might need something stronger than a martini as Jim and Greg dig into three big stories today. First, they respond to the congressional testimony of former CDC Director Dr. Robert Redfield, who said our top officials knew from the start that COVID... by 3 Martini Lunch
26 min listen
The Interview - The Second Wave Is Going to Be Much, Much Worse: Dr. Dena Grayson speaks to Pedro Da Costa about the ongoing efforts of medical professionals to save lives & stop the COVID-19 pandemic in its tracks. by Real Vision: Finance & Investing
47 min listen
Greg Verdine: Greg Verdine is a professor at Harvard University, and CEO and president of FogPharma and LifeMine Therapeutics. He is co-founder of more than 10 companies. His talk with Nature Biotechnology covers growing up in the Pine Barrens of New Jersey, the imp... by First Rounders
73 min listen

Discover this podcast and so much more

All Eyes on Gilead

All Eyes on Gilead

Description

Titles in the series (100)

More Episodes from Listen to the Story

Related podcast episodes